Search For "drug controller"
Equity indices trade strong, Sensex jumps 48K mark
Updated : 1 week, 5 days ago IST
Mumbai (Maharashtra) [India], January 4 (ANI): Equity benchmark indices continued their upward march during early hours on Monday after the Drug Controller General of India approved Covid vaccines produced by AstraZeneca and Bharat Biotech for emergency use in the country.
Read More
Indigenous mRNA vaccine candidate supported by DBT gets Drug Contr
Updated : 1 month ago IST
New Delhi [India], December 11 (ANI): In a major development in the fight against COVID-19, India's first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial.
Read More
Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volu
Updated : 2 months, 3 weeks ago IST
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Read More
DCGI approves India's first CRISPR Covid-19 test developed by the
Updated : 3 months, 4 weeks ago IST
New Delhi [India], September 19 (ANI): The Drug Controller General of India (DCGI), on Saturday gave approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) test, developed by the Tata Group and CSIR-IGIB (Institute of Genomics a
Read More
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treat
Updated : 4 months, 1 week ago IST
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
Read More
Lupin launches Favipiravir in India for COVID treatment at Rs 49 p
Updated : 5 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to
Updated : 5 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remde
Updated : 5 months, 4 weeks ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with P
Updated : 6 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
DCGI gives market approval for Pneumococcal Polysaccharide Conjuga
Updated : 6 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine.
Read More
DCGI approves Itolizumab injection for restricted emergency use on
Updated : 6 months, 1 week ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Read More
COVID19: Top drug regulator directs states drug controller to be v
Updated : 6 months, 1 week ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More